查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1605868

药物研发AI市场，规模，占有率，趋势，产业分析报告:各提供，各技术，各治疗领域，各用途，各终端用户，各地区 - 市场预测 2025年～2034年

AI in Drug Discovery Market Size, Share, Trends, Industry Analysis Report: By Offering, By Technology, By Therapeutic Area, By Application, By End User, and By Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 120 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris Market Research 的最新研究，到 2034 年，药物发现 AI 市场预计将达到 264.9779 亿美元。该研究报告提供了对当前市场动态的详细洞察，并对未来市场成长进行了分析。

由于技术进步的快速采用、医疗保健需求的增加以及製药业不断发展的动态，药物发现人工智慧市场正在经历快速成长。对更高效、更具成本效益的药物开发流程的需求不断增长，正在推动对药物发现人工智慧市场的需求。传统的药物发现方法往往耗时且成本高昂，且在临床试验过程中失败率很高。人工智慧透过加速识别潜在候选药物、预测疗效和安全性以及优化临床试验设计来提供解决方案。这减少了与药物开发相关的时间和成本，有助于市场开发。此外，慢性病的流行和对个人化医疗日益增长的需求正在推动药物发现解决方案对人工智慧的需求。随着人口老化以及癌症、糖尿病和心血管疾病等疾病发病率的增加，对新的、更有效的治疗方法的需求日益增长。人工智慧技术，包括机器学习和深度学习，特别适合分析大型资料集并识别使用传统方法可能不明显的模式。这种能力将使开发针对个别患者情况的针对性治疗成为可能，从而改善治疗结果并减少副作用。

公共和私营部门的大量投资推动了药物发现人工智慧的采用。世界各地的政府和医疗保健组织正在认识到人工智慧彻底改变药物发现过程的潜力，并投资研发计画以加速创新。此外，人工智慧技术公司与製药巨头之间的合作也在不断增加，旨在将人工智慧融入药物开发的各个阶段。这些合作得到了运算能力、云端运算和大数据分析的进步进一步支持，为药物发现人工智慧应用提供了必要的基础设施。

药物发现人工智慧市场报告亮点

到2024 年，由于对创新癌症治疗的高需求以及癌症研究的复杂性，肿瘤学领域将在药物发现人工智慧市场中占据最大的收入占有率，这极大地受益于人工智慧驱动的解决方案。

据预测，随着人工智慧技术的采用加速药物发现、降低开发成本并提高药物开发过程的准确性和效率，製药和生物技术公司部门将以最快的复合年增长率增长。

2024 年，在先进的医疗基础设施、对人工智慧研究的高额投资以及大型製药公司利用人工智慧进行药物开发的推动下，北美在药物发现人工智慧市场中占据最大的市场占有率。技术公司的存在。

亚太地区在预测期内将出现最快的复合年增长率，因为其庞大且多样化的患者群体提供了宝贵的数据和政府支持措施，以促进预计将增长的药物发现创新。

目录

第1章 简介

第2章 摘要整理

第3章 调查手法

第4章 药物研发AI市场世界的洞察

  • 应用概述
  • 药物研发市场动态
    • 促进因素和机会
      • 製药公司与人工智慧提供者之间的合作将推动市场成长
      • 人工智慧技术的进步正在推动市场成长。
    • 抑制因素和挑战
      • 资料隐私和安全问题限制了药物发现人工智慧市场的成长
  • PESTEL分析
  • 药物研发市场上AI的应用趋势
  • 价值链分析
  • COVID-19影响分析

第5章 药物研发AI市场世界的趋势:各提供

  • 主要调查结果
  • 简介
  • 软体
  • 服务

第6章 全球药物研发AI市场:各技术

  • 主要调查结果
  • 简介
  • 机器学习
  • 其他的科技

第7章 全球药物研发AI市场:各治疗领域

  • 主要调查结果
  • 简介
  • 肿瘤学
  • 神经退化性疾病
  • 心血管疾病
  • 代谢性疾病
  • 感染疾病
  • 其他

第8章 全球药物研发AI市场:各用途

  • 主要调查结果
  • 简介
  • 医药品的最佳化与再利用
  • 临床试验前
  • 其他

第9章 全球药物研发AI市场:各终端用户

  • 主要调查结果
  • 简介
  • 製药·生物科技企业
  • 契约调查机关
  • 研究中心
  • 学术机构及政府机关

第10章 全球药物研发AI市场:各地区

  • 主要调查结果
  • 简介
    • 药物研发AI市场评估:各地区，2020～2034年
  • 北美
    • 北美:各提供，2020～2034年
    • 北美:各技术，2020～2034年
    • 北美:各治疗领域，2020年～2034年
    • 北美:各用途，2020～2034年
    • 北美:各终端用户，2020～2034年
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲:各提供，2020～2034年
    • 欧洲:各技术，2020～2034年
    • 欧洲:各治疗领域，2020～2034年
    • 欧洲:各用途，2020～2034年
    • 欧洲:各终端用户，2020～2034年
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
    • 其他欧洲
  • 亚太地区
    • 亚太地区:各提供，2020年～2034年
    • 亚太地区:各技术，2020～2034年
    • 亚太地区:各治疗领域，2020年～2034年
    • 亚太地区:各用途，2020～2034年
    • 亚太地区:各终端用户，2020～2034年
    • 中国
    • 印度
    • 马来西亚
    • 日本
    • 印尼
    • 韩国
    • 澳洲
    • 其他亚太地区
  • 中东·非洲
    • 中东·非洲:各提供，2020～2034年
    • 中东·非洲:各技术，2020～2034年
    • 中东·非洲:各治疗领域，2020～2034年
    • 中东·非洲:各用途，2020～2034年
    • 中东·非洲:各终端用户，2020～2034年
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 以色列
    • 南非
    • 其他中东和非洲
  • 南美
    • 南美:各提供，2020～2034年
    • 南美:各技术，2020～2034年
    • 南美:各治疗领域，2020～2034年
    • 南美:各用途，2020～2034年
    • 南美:各终端用户，2020～2034年
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美国家

第11章 竞争情形

  • 扩大和收购的分析
    • 扩大
    • 收购
  • 联盟/合作/协定/公开

第12章 企业简介

  • Atomwise Inc.
  • BenevolentAI
  • Berg Health
  • BioSymetrics, Inc.
  • CYCLICA
  • Exscientia
  • GNS Healthcare
  • Google
  • IBM
  • Insilico Medicine
  • insitro
Product Code: PM1850

The AI in drug discovery market size is expected to reach USD 26,497.79 million by 2034, according to a new study by Polaris Market Research. The report "AI in Drug Discovery Market Share, Size, Trends, Industry Analysis Report, By Offering (Software, Services), By Technology, By Therapeutic Area, By Application, By End User and By Region (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa); Segment Forecast, 2025 - 2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The AI in drug discovery market is experiencing rapid growth, due to rapid adoption of technological advancements, increasing healthcare needs, and evolving pharmaceutical industry dynamics. The escalating demand for more efficient and cost-effective drug development processes is driving demand for the AI in drug discovery market. Traditional drug discovery methods are often time-consuming and expensive, with high failure rates during clinical trials. AI offers a solution by accelerating the identification of potential drug candidates, predicting their efficacy and safety, and optimizing clinical trial designs. This reduces the time and cost associated with drug development, thus contributing to the market growth. Furthermore, the growing prevalence of chronic diseases and the increasing need for personalized medicine is driving demand for AI in drug discovery solutions. With rising aging population and increasing incidence of conditions such as cancer, diabetes, and cardiovascular diseases rises, there is a growing need for new and more effective therapies. AI technologies, including machine learning and deep learning, are particularly well-suited to analyzing large datasets and identifying patterns that may not be apparent through traditional methods. This capability enables the development of targeted therapies tailored to individual patient profiles, improving treatment outcomes and reducing adverse effects.

The adoption of AI in drug discovery is being fueled by substantial investments from both private and public sectors. Governments and healthcare organizations worldwide are recognizing the potential of AI to revolutionize the drug discovery process and are investing in research and development initiatives to foster innovation. Moreover, collaborations between AI technology companies and pharmaceutical giants are also on the rise, with partnerships aimed at integrating AI into various stages of drug development. These collaborations are further supported by advancements in computational power, cloud computing, and big data analytics, which provide the necessary infrastructure for AI applications in drug discovery.

AI in Drug Discovery Market Report Highlights

In 2024, the oncology segment accounted for the largest revenue share in the AI in drug discovery market due to the high demand for innovative cancer treatments and the complexity of cancer research, which benefits significantly from AI-driven solutions.

The pharmaceutical & biotechnology companies segment is anticipated to grow at the fastest CAGR due to their increasing adoption of AI technologies to accelerate drug discovery, reduce development costs, and enhance the precision and efficiency of drug development processes.

In 2024, North America accounted for the largest market share in the AI in drug discovery market due to its advanced healthcare infrastructure, high levels of investment in AI research, and the presence of major pharmaceutical and biotechnology companies leveraging AI for drug development.

The Asia Pacific region is expected to grow at the fastest CAGR in the forecast period due to a large and diverse patient population providing valuable data, and supportive government initiatives fostering innovation in drug discovery.

The global key market players include Atomwise Inc., BenevolentAI, Berg Health (Berg Health acquired by BPGbio Inc.), BioSymetrics, Inc., CYCLICA (Acquired by Recursion Pharmaceuticals), Exscientia, GNS Healthcare (the company Rebranded as Aitia), Google (DeepMind), IBM, Insilico Medicine, insitro.

Polaris Market Research has segmented the AI in drug discovery market report based on offering, technology, therapeutic area, application, end user, and region:

By Offering Outlook (Revenue - USD million, 2020-2034)

  • Software
  • Services

By Technology Outlook (Revenue - USD million, 2020-2034)

  • Machine Learning
  • Deep Learning
  • Supervised Learning
  • Reinforcement Learning
  • Unsupervised Learning
  • Other Machine Learning Technologies
  • Other Technologies

By Therapeutic Area Outlook (Revenue - USD million, 2020-2034)

  • Oncology
  • Neurodegenerative Diseases
  • Cardiovascular Disease
  • Metabolic Diseases
  • Infectious Disease
  • Others

By Application Outlook (Revenue - USD million, 2020-2034)

  • Drug optimization & repurposing
  • Preclinical testing
  • Others

By End User Outlook (Revenue - USD million, 2020-2034)

  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations
  • Research Centers
  • Academic & Government Institutes

By Regional Outlook (Revenue - USD million, 2020-2034)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Rest of Asia Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global AI in Drug Discovery Market Insights

  • 4.1. AI in Drug Discovery Market - Application Snapshot
  • 4.2. AI in Drug Discovery Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Collaboration Between Pharma Companies and AI Providers is Driving Market Growth
      • 4.2.1.2. The Advancements in AI Technology Are Driving the Market Growth.
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Data Privacy and Security Concerns are limiting the growth of AI in Drug Discovery market
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. AI in Drug Discovery Market Application Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global AI in Drug Discovery Market, by Offering

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • 5.3. Software
    • 5.3.1. Global AI in Drug Discovery Market, by Software, by Region, 2020-2034 (USD Million)
  • 5.4. Services
    • 5.4.1. Global AI in Drug Discovery Market, by Services , by Region, 2020-2034 (USD Million)

6. Global AI in Drug Discovery Market, by Technology

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • 6.3. Machine Learning
    • 6.3.1. Global AI in Drug Discovery Market, by Machine Learning, by Region, 2020-2034 (USD Million)
    • 6.3.2. Deep Learning
      • 6.3.2.1. Global AI in Drug Discovery Market, by Deep Learning, by Region, 2020-2034 (USD Million)
    • 6.3.3. Supervised Learning
      • 6.3.3.1. Global AI in Drug Discovery Market, by Supervised Learning, by Region, 2020-2034 (USD Million)
    • 6.3.4. Reinforcement Learning
      • 6.3.4.1. Global AI in Drug Discovery Market, by Reinforcement Learning, by Region, 2020-2034 (USD Million)
    • 6.3.5. Unsupervised Learning
      • 6.3.5.1. Global AI in Drug Discovery Market, by Unsupervised Learning, by Region, 2020-2034 (USD Million)
    • 6.3.6. Other Machine Learning Technologies
      • 6.3.6.1. Global AI in Drug Discovery Market, by Other Machine Learning Technologies, by Region, 2020-2034 (USD Million)
  • 6.4. Other Technologies
    • 6.4.1. Global AI in Drug Discovery Market, by Other Technologies, by Region, 2020-2034 (USD Million)

7. Global AI in Drug Discovery Market, by Therapeutic Area

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • 7.3. Oncology
    • 7.3.1. Global AI in Drug Discovery Market, by Oncology, by Region, 2020-2034 (USD Million)
  • 7.4. Neurodegenerative Diseases
    • 7.4.1. Global AI in Drug Discovery Market, by Neurodegenerative Diseases, by Region, 2020-2034 (USD Million)
  • 7.5. Cardiovascular Disease
    • 7.5.1. Global AI in Drug Discovery Market, by Cardiovascular Disease, by Region, 2020-2034 (USD Million)
  • 7.6. Metabolic Diseases
    • 7.6.1. Global AI in Drug Discovery Market, by Metabolic Diseases, by Region, 2020-2034 (USD Million)
  • 7.7. Infectious Disease
    • 7.7.1. Global AI in Drug Discovery Market, by Infectious Disease, by Region, 2020-2034 (USD Million)
  • 7.8. Others
    • 7.8.1. Global AI in Drug Discovery Market, by Others, by Region, 2020-2034 (USD Million)

8. Global AI in Drug Discovery Market, by Application

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • 8.3. Drug optimization & repurposing
    • 8.3.1. Global AI in Drug Discovery Market, by Drug optimization & repurposing, by Region, 2020-2034 (USD Million)
  • 8.4. Preclinical testing
    • 8.4.1. Global AI in Drug Discovery Market, by Preclinical testing, by Region, 2020-2034 (USD Million)
  • 8.5. Others
    • 8.5.1. Global AI in Drug Discovery Market, by Others, by Region, 2020-2034 (USD Million)

9. Global AI in Drug Discovery Market, by End User

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Global AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • 9.3. Pharmaceutical & Biotechnology Companies
    • 9.3.1. Global AI in Drug Discovery Market, by Pharmaceutical & Biotechnology Companies, by Region, 2020-2034 (USD Million)
  • 9.4. Contract Research Organizations
    • 9.4.1. Global AI in Drug Discovery Market, by Contract Research Organizations, by Region, 2020-2034 (USD Million)
  • 9.5. Research Centers
    • 9.5.1. Global AI in Drug Discovery Market, by Research Centers, by Region, 2020-2034 (USD Million)
  • 9.6. Academic & Government Institutes
    • 9.6.1. Global AI in Drug Discovery Market, by Academic & Government Institutes, by Region, 2020-2034 (USD Million)

10. Global AI in Drug Discovery Market, by Geography

  • 10.1. Key Findings
  • 10.2. Introduction
    • 10.2.1. AI in Drug Discovery Market Assessment, By Geography, 2020-2034 (USD Million)
  • 10.3. AI in Drug Discovery Market - North America
    • 10.3.1. North America: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
    • 10.3.2. North America: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
    • 10.3.3. North America: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
    • 10.3.4. North America: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
    • 10.3.5. North America: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
    • 10.3.7. AI in Drug Discovery Market - U.S.
      • 10.3.7.1. U.S.: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
      • 10.3.7.2. U.S.: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
      • 10.3.7.3. U.S.: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 10.3.7.4. U.S.: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
      • 10.3.7.5. U.S.: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
    • 10.3.8. AI in Drug Discovery Market - Canada
      • 10.3.8.1. Canada: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
      • 10.3.8.2. Canada: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
      • 10.3.8.3. Canada: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 10.3.8.4. Canada: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
      • 10.3.8.5. Canada: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • 10.4. AI in Drug Discovery Market - Europe
    • 10.4.1. Europe: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
    • 10.4.2. Europe: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
    • 10.4.3. Europe: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
    • 10.4.4. Europe: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
    • 10.4.5. Europe: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
    • 10.4.6. AI in Drug Discovery Market - UK
      • 10.4.6.1. UK: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
      • 10.4.6.2. UK: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
      • 10.4.6.3. UK: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 10.4.6.4. UK: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
      • 10.4.6.5. UK: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
    • 10.4.7. AI in Drug Discovery Market - France
      • 10.4.7.1. France: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
      • 10.4.7.2. France: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
      • 10.4.7.3. France: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 10.4.7.4. France: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
      • 10.4.7.5. France: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
    • 10.4.8. AI in Drug Discovery Market - Germany
      • 10.4.8.1. Germany: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
      • 10.4.8.2. Germany: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
      • 10.4.8.3. Germany: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 10.4.8.4. Germany: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
      • 10.4.8.5. Germany: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
    • 10.4.9. AI in Drug Discovery Market - Italy
      • 10.4.9.1. Italy: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
      • 10.4.9.2. Italy: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
      • 10.4.9.3. Italy: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 10.4.9.4. Italy: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
      • 10.4.9.5. Italy: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
    • 10.4.10. AI in Drug Discovery Market - Spain
      • 10.4.10.1. Spain: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
      • 10.4.10.2. Spain: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
      • 10.4.10.3. Spain: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 10.4.10.4. Spain: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
      • 10.4.10.5. Spain: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
    • 10.4.11. AI in Drug Discovery Market - Netherlands
      • 10.4.11.1. Netherlands: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
      • 10.4.11.2. Netherlands: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
      • 10.4.11.3. Netherlands: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 10.4.11.4. Netherlands: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
      • 10.4.11.5. Netherlands: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
    • 10.4.12. AI in Drug Discovery Market - Russia
      • 10.4.12.1. Russia: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
      • 10.4.12.2. Russia: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
      • 10.4.12.3. Russia: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 10.4.12.4. Russia: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
      • 10.4.12.5. Russia: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
    • 10.4.13. AI in Drug Discovery Market - Rest of Europe
      • 10.4.13.1. Rest of Europe: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
      • 10.4.13.2. Rest of Europe: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
      • 10.4.13.3. Rest of Europe: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 10.4.13.4. Rest of Europe: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
      • 10.4.13.5. Rest of Europe: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • 10.5. AI in Drug Discovery Market - Asia Pacific
    • 10.5.1. Asia Pacific: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
    • 10.5.2. Asia Pacific: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
    • 10.5.3. Asia Pacific: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
    • 10.5.4. Asia Pacific: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
    • 10.5.5. Asia Pacific: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
    • 10.5.6. AI in Drug Discovery Market - China
      • 10.5.6.1. China: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
      • 10.5.6.2. China: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
      • 10.5.6.3. China: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 10.5.6.4. China: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
      • 10.5.6.5. China: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
    • 10.5.7. AI in Drug Discovery Market - India
      • 10.5.7.1. India: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
      • 10.5.7.2. India: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
      • 10.5.7.3. India: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 10.5.7.4. India: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
      • 10.5.7.5. India: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
    • 10.5.8. AI in Drug Discovery Market - Malaysia
      • 10.5.8.1. Malaysia: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
      • 10.5.8.2. Malaysia: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
      • 10.5.8.3. Malaysia: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 10.5.8.4. Malaysia: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
      • 10.5.8.5. Malaysia: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
    • 10.5.9. AI in Drug Discovery Market - Japan
      • 10.5.9.1. Japan: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
      • 10.5.9.2. Japan: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
      • 10.5.9.3. Japan: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 10.5.9.4. Japan: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
      • 10.5.9.5. Japan: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
    • 10.5.10. AI in Drug Discovery Market - Indonesia
      • 10.5.10.1. Indonesia: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
      • 10.5.10.2. Indonesia: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
      • 10.5.10.3. Indonesia: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 10.5.10.4. Indonesia: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
      • 10.5.10.5. Indonesia: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
    • 10.5.11. AI in Drug Discovery Market - South Korea
      • 10.5.11.1. South Korea: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
      • 10.5.11.2. South Korea: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
      • 10.5.11.3. South Korea: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 10.5.11.4. South Korea: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
      • 10.5.11.5. South Korea: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
    • 10.5.12. AI in Drug Discovery Market - Australia
      • 10.5.12.1. Australia: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
      • 10.5.12.2. Australia: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
      • 10.5.12.3. Australia: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 10.5.12.4. Australia: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
      • 10.5.12.5. Australia: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
    • 10.5.13. AI in Drug Discovery Market - Rest of Asia Pacific
      • 10.5.13.1. Rest of Asia Pacific: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
      • 10.5.13.2. Rest of Asia Pacific: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
      • 10.5.13.3. Rest of Asia Pacific: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 10.5.13.4. Rest of Asia Pacific: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
      • 10.5.13.5. Rest of Asia Pacific: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • 10.6. AI in Drug Discovery Market - Middle East & Africa
    • 10.6.1. Middle East & Africa: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
    • 10.6.2. Middle East & Africa: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
    • 10.6.3. Middle East & Africa: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
    • 10.6.4. Middle East & Africa: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
    • 10.6.5. Middle East & Africa: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
    • 10.6.6. AI in Drug Discovery Market - Saudi Arabia
      • 10.6.6.1. Saudi Arabia: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
      • 10.6.6.2. Saudi Arabia: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
      • 10.6.6.3. Saudi Arabia: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 10.6.6.4. Saudi Arabia: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
      • 10.6.6.5. Saudi Arabia: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
    • 10.6.7. AI in Drug Discovery Market - UAE
      • 10.6.7.1. UAE: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
      • 10.6.7.2. UAE: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
      • 10.6.7.3. UAE: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 10.6.7.4. UAE: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
      • 10.6.7.5. UAE: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
    • 10.6.8. AI in Drug Discovery Market - Israel
      • 10.6.8.1. Israel: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
      • 10.6.8.2. Israel: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
      • 10.6.8.3. Israel: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 10.6.8.4. Israel: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
      • 10.6.8.5. Israel: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
    • 10.6.9. AI in Drug Discovery Market - South Africa
      • 10.6.9.1. South Africa: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
      • 10.6.9.2. South Africa: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
      • 10.6.9.3. South Africa: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 10.6.9.4. South Africa: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
      • 10.6.9.5. South Africa: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
    • 10.6.10. AI in Drug Discovery Market - Rest of Middle East & Africa
      • 10.6.10.1. Rest of Middle East & Africa: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
      • 10.6.10.2. Rest of Middle East & Africa: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
      • 10.6.10.3. Rest of Middle East & Africa: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 10.6.10.4. Rest of Middle East & Africa: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
      • 10.6.10.5. Rest of Middle East & Africa: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • 10.7. AI in Drug Discovery Market - Latin America
    • 10.7.1. Latin America: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
    • 10.7.2. Latin America: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
    • 10.7.3. Latin America: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
    • 10.7.4. Latin America: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
    • 10.7.5. Latin America: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
    • 10.7.6. AI in Drug Discovery Market - Mexico
      • 10.7.6.1. Mexico: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
      • 10.7.6.2. Mexico: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
      • 10.7.6.3. Mexico: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 10.7.6.4. Mexico: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
      • 10.7.6.5. Mexico: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
    • 10.7.7. AI in Drug Discovery Market - Brazil
      • 10.7.7.1. Brazil: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
      • 10.7.7.2. Brazil: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
      • 10.7.7.3. Brazil: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 10.7.7.4. Brazil: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
      • 10.7.7.5. Brazil: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
    • 10.7.8. AI in Drug Discovery Market - Argentina
      • 10.7.8.1. Argentina: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
      • 10.7.8.2. Argentina: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
      • 10.7.8.3. Argentina: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 10.7.8.4. Argentina: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
      • 10.7.8.5. Argentina: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
    • 10.7.9. AI in Drug Discovery Market - Rest of Latin America
      • 10.7.9.1. Rest of Latin America: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
      • 10.7.9.2. Rest of Latin America: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
      • 10.7.9.3. Rest of Latin America: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
      • 10.7.9.4. Rest of Latin America: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
      • 10.7.9.5. Rest of Latin America: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)

11. Competitive Landscape

  • 11.1. Expansion and Acquisition Analysis
    • 11.1.1. Expansion
    • 11.1.2. Acquisitions
  • 11.2. Partnerships/Collaborations/Agreements/Exhibitions

12. Company Profiles

  • 12.1. Atomwise Inc.
    • 12.1.1. Company Overview
    • 12.1.2. Financial Performance
    • 12.1.3. Product Benchmarking
    • 12.1.4. Recent Development
  • 12.2. BenevolentAI
    • 12.2.1. Company Overview
    • 12.2.2. Financial Performance
    • 12.2.3. Product Benchmarking
    • 12.2.4. Recent Development
  • 12.3. Berg Health
    • 12.3.1. Company Overview
    • 12.3.2. Financial Performance
    • 12.3.3. Product Benchmarking
    • 12.3.4. Recent Development
  • 12.4. BioSymetrics, Inc.
    • 12.4.1. Company Overview
    • 12.4.2. Financial Performance
    • 12.4.3. Product Benchmarking
    • 12.4.4. Recent Development
  • 12.5. CYCLICA
    • 12.5.1. Company Overview
    • 12.5.2. Financial Performance
    • 12.5.3. Product Benchmarking
    • 12.5.4. Recent Development
  • 12.6. Exscientia
    • 12.6.1. Company Overview
    • 12.6.2. Financial Performance
    • 12.6.3. Product Benchmarking
    • 12.6.4. Recent Development
  • 12.7. GNS Healthcare
    • 12.7.1. Company Overview
    • 12.7.2. Financial Performance
    • 12.7.3. Product Benchmarking
    • 12.7.4. Recent Development
  • 12.8. Google
    • 12.8.1. Company Overview
    • 12.8.2. Financial Performance
    • 12.8.3. Product Benchmarking
    • 12.8.4. Recent Development
  • 12.9. IBM
    • 12.9.1. Company Overview
    • 12.9.2. Financial Performance
    • 12.9.3. Product Benchmarking
    • 12.9.4. Recent Development
  • 12.10. Insilico Medicine
    • 12.10.1. Company Overview
    • 12.10.2. Financial Performance
    • 12.10.3. Product Benchmarking
    • 12.10.4. Recent Development
  • 12.11. insitro
    • 12.11.1. Company Overview
    • 12.11.2. Financial Performance
    • 12.11.3. Product Benchmarking
    • 12.11.4. Recent Development

List of Tables:

  • Table 1 Global AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 2 Global AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 3 Global AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 4 Global AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 5 Global AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 6 North America: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 7 North America: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 8 North America: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 9 North America: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 10 North America: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 11 U.S.: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 12 U.S.: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 13 U.S.: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 14 U.S.: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 15 U.S.: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 16 Canada: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 17 Canada: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 18 Canada: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 19 Canada: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 20 Canada: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 21 Europe: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 22 Europe: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 23 Europe: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 24 Europe: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 25 Europe: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 26 UK: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 27 UK: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 28 UK: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 29 UK: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 30 UK: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 31 France: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 32 France: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 33 France: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 34 France: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 35 France: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 36 Germany: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 37 Germany: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 38 Germany: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 39 Germany: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 40 Germany: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 41 Italy: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 42 Italy: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 43 Italy: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 44 Italy: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 45 Italy: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 46 Spain: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 47 Spain: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 48 Spain: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 49 Spain: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 50 Spain: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 51 Netherlands: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 52 Netherlands: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 53 Netherlands: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 54 Netherlands: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 55 Netherlands: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 56 Russia: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 57 Russia: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 58 Russia: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 59 Russia: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 60 Russia: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 61 Rest of Europe: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 62 Rest of Europe: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 63 Rest of Europe: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 64 Rest of Europe: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 65 Rest of Europe: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 66 Asia Pacific: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 67 Asia Pacific: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 68 Asia Pacific: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 69 Asia Pacific: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 70 Asia Pacific: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 71 China: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 72 China: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 73 China: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 74 China: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 75 China: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 76 India: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 77 India: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 78 India: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 79 India: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 80 India: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 81 Malaysia: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 82 Malaysia: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 83 Malaysia: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 84 Malaysia: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 85 Malaysia: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 86 Japan: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 87 Japan: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 88 Japan: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 89 Japan: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 90 Japan: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 91 Indonesia: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 92 Indonesia: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 93 Indonesia: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 94 Indonesia: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 95 Indonesia: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 96 South Korea: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 97 South Korea: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 98 South Korea: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 99 South Korea: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 100 South Korea: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 101 Australia: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 102 Australia: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 103 Australia: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 104 Australia: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 105 Australia: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 106 Rest of Asia Pacific: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 107 Rest of Asia Pacific: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 108 Rest of Asia Pacific: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 109 Rest of Asia Pacific: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 110 Rest of Asia Pacific: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 111 Middle East & Africa: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 112 Middle East & Africa: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 113 Middle East & Africa: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 114 Middle East & Africa: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 115 Middle East & Africa: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 116 Saudi Arabia: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 117 Saudi Arabia: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 118 Saudi Arabia: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 119 Saudi Arabia: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 120 Saudi Arabia: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 121 UAE: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 122 UAE: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 123 UAE: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 124 UAE: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 125 UAE: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 126 Israel: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 127 Israel: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 128 Israel: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 129 Israel: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 130 Israel: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 131 South Africa: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 132 South Africa: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 133 South Africa: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 134 South Africa: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 135 South Africa: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 136 Rest of Middle East & Africa: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 137 Rest of Middle East & Africa: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 138 Rest of Middle East & Africa: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 139 Rest of Middle East & Africa: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 140 Rest of Middle East & Africa: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 141 Latin America: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 142 Latin America: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 143 Latin America: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 144 Latin America: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 145 Latin America: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 146 Mexico: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 147 Mexico: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 148 Mexico: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 149 Mexico: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 150 Mexico: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 151 Brazil: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 152 Brazil: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 153 Brazil: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 154 Brazil: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 155 Brazil: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 156 Argentina: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 157 Argentina: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 158 Argentina: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 159 Argentina: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 160 Argentina: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • Table 161 Rest of Latin America: AI in Drug Discovery Market, by Offering, 2020-2034 (USD Million)
  • Table 162 Rest of Latin America: AI in Drug Discovery Market, by Technology, 2020-2034 (USD Million)
  • Table 163 Rest of Latin America: AI in Drug Discovery Market, by Therapeutic Area, 2020-2034 (USD Million)
  • Table 164 Rest of Latin America: AI in Drug Discovery Market, by Application, 2020-2034 (USD Million)
  • Table 165 Rest of Latin America: AI in Drug Discovery Market, by End User, 2020-2034 (USD Million)
  • List of Figures:
  • Figure 1. Global AI in Drug Discovery Market, 2020-2034 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Offering
  • Figure 7. Global AI in Drug Discovery Market, by Offering, 2024 & 2034 (USD Million)
  • Figure 8. Market by Technology
  • Figure 9. Global AI in Drug Discovery Market, by Technology, 2024 & 2034 (USD Million)
  • Figure 10. Market by Therapeutic Area
  • Figure 11. Global AI in Drug Discovery Market, by Therapeutic Area, 2024 & 2034 (USD Million)
  • Figure 12. Market by Application
  • Figure 13. Global AI in Drug Discovery Market, by Application, 2024 & 2034 (USD Million)
  • Figure 14. Market by End User
  • Figure 15. Global AI in Drug Discovery Market, by End User, 2024 & 2034 (USD Million)